Herman Spolders
Keine laufenden Positionen mehr
Profil
Herman Spolders was the founder of MDxHealth SA, which was founded in 2003, where he held the title of Chief Executive Officer from 2003 to 2010.
He was also the founder of Pluriomics BV, which was founded in 2010, where he held the title of Chairman.
In addition to his founding positions, Dr. Spolders worked as a Director at Ncardia SA.
Ehemalige bekannte Positionen von Herman Spolders
| Unternehmen | Position | Ende |
|---|---|---|
Pluriomics BV
 Pluriomics BV BiotechnologyHealth Technology Pluriomics BV provides cardiac drug discovery and safety assessment solutions. The company was founded by Stefan Braam, Christine Mummery, Robert Passier and Herman Spolders in 2010 and is headquartered in Leiden, the Netherlands. | Gründer | - |
Ncardia SA
 Ncardia SA Miscellaneous Commercial ServicesCommercial Services Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium. | Direktor/Vorstandsmitglied | - |
| MDXHEALTH SA | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MDXHEALTH SA | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Pluriomics BV
Pluriomics BV BiotechnologyHealth Technology Pluriomics BV provides cardiac drug discovery and safety assessment solutions. The company was founded by Stefan Braam, Christine Mummery, Robert Passier and Herman Spolders in 2010 and is headquartered in Leiden, the Netherlands. | Health Technology |
Ncardia SA
Ncardia SA Miscellaneous Commercial ServicesCommercial Services Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium. | Commercial Services |